One study [44] observed fewer activated CD8+ T cells in invasive breast cancer than in-ductal carcinoma in situ (DCIS), proposing that immune evasion occurs during the transition from DCIS to invasive cancer. This evidence concerns the gene CD8A and invasive breast carcinoma.